These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2157515)

  • 21. Prevention of Rh-immunization in Sweden.
    Bartsch FK; Sandberg L; Unander M
    Pathologica; 1972; 64(929):111-4. PubMed ID: 4210412
    [No Abstract]   [Full Text] [Related]  

  • 22. Controversies in Rh prophylaxis.
    Hensleigh PA
    Am J Obstet Gynecol; 1985 Sep; 153(1):112-3. PubMed ID: 2994476
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 24. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.
    Kumpel BM
    Clin Exp Immunol; 2008 Oct; 154(1):1-5. PubMed ID: 18727626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum sickness due to Rh(anti-D) immunoglobulin.
    Jones BF; Trevillian PR; Nanra RS
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):49-50. PubMed ID: 6331369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rh haemolytic disease of the newborn: the role of the laboratory.
    Tovey LA
    Med Lab Sci; 1982 Jul; 39(3):297-303. PubMed ID: 6813628
    [No Abstract]   [Full Text] [Related]  

  • 27. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 29. Is the recommended minimum dose of anti-D adequate considering the rise in obesity?
    Regan FA; Naftalin J; Springer V; Paterson-Brown S
    Transfus Med; 2008 Aug; 18(4):266-8. PubMed ID: 18783586
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 31. An analysis of the efficiency of a Rhesus haemolytic disease prophylaxis programme.
    Crowle PM
    Br J Prev Soc Med; 1974 May; 28(2):101-3. PubMed ID: 4211794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunization hemolytic disease of the newborn (HDN) Rh with anti-D immunoglobulins].
    Moggian G; Tamburini E
    Ann Sclavo; 1974; 16(1):91-100. PubMed ID: 4214488
    [No Abstract]   [Full Text] [Related]  

  • 34. [Advances in neonatology: vitamin K, intracranial hemorrhage, arterial pressure, hemolytic disease].
    Jiménez R
    An Esp Pediatr; 1984 Oct; 21(5):447-52. PubMed ID: 6095712
    [No Abstract]   [Full Text] [Related]  

  • 35. [Status of rhesus prevention in the year 1982].
    Schneider J
    Arch Gynecol; 1983; 235(1-4):411-8. PubMed ID: 6314914
    [No Abstract]   [Full Text] [Related]  

  • 36. The dose of anti-D immunoglobulin.
    Hamblin T; Daoud M
    Lancet; 1977 Apr; 1(8015):795. PubMed ID: 66586
    [No Abstract]   [Full Text] [Related]  

  • 37. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].
    di Maria H; Parnet Mathieu F; Rio di Maria D; Maigret P; Gire R; Guillot F; Lasfargues G; Brossard Y
    Arch Fr Pediatr; 1990 Feb; 47(2):125-7. PubMed ID: 2158285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is antenatal antibody screening worthwhile in Chinese?
    Wong KF; Tse KT; Lee AW; Mak CS; So CC
    Br J Haematol; 1997 Jun; 97(4):917-9. PubMed ID: 9217197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced severity of Rh-haemolytic disease after anti-D immunoglobulin.
    Derrick Tovey LA; Robinson AE
    Br Med J; 1975 Nov; 4(5992):320-2. PubMed ID: 811308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.